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Heat shock protein 70
ATPPrior exposure to sub toxic insults can induce a powerful endogenous neuroprotective program known as
ischemic preconditioning. Current models typically rely on a single stress episode to induce neuroprotection
whereas the clinical reality is that patients may experience multiple transient ischemic attacks (TIAs) prior to
suffering a stroke. We sought to develop a neuron-enriched preconditioning model using multiple oxygen
glucose deprivation (OGD) episodes to assess the endogenous protective mechanisms neurons implement at
the metabolic and cellular level. We found that neurons exposed to a ﬁve minute period of glucose
deprivation recovered oxygen utilization and lactate production using novel microphysiometry techniques.
Using the non-toxic and energetically favorable ﬁve minute exposure, we developed a preconditioning
paradigm where neurons are exposed to this brief OGD for three consecutive days. These cells experienced a
45% greater survival following an otherwise lethal event and exhibited a longer lasting window of protection
in comparison to our previous in vitro preconditioning model using a single stress. As in other models,
preconditioned cells exhibited mild caspase activation, an increase in oxidized proteins and a requirement
for reactive oxygen species for neuroprotection. Heat shock protein 70 was upregulated during
preconditioning, yet the majority of this protein was released extracellularly. We believe coupling this
neuron-enriched multi-day model with microphysiometry will allow us to assess neuronal speciﬁc real-time
metabolic adaptations necessary for preconditioning.70, heat shock protein 70; TIA,
; LDH, lactate dehydrogenase;
in; LOx, lactate oxidase; MAP2,
henylnitrone; PBS, phosphate
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Stroke is the second leading cause of death and most common
cause of long term adult disability worldwide [1]. Given that 87% of
strokes are ischemic in nature [2], there is a pressing need to
understand the pathophysiology of ischemic cell death. Developing
neurotherapeutic agents based on our current understanding of thecytotoxic signaling pathways associated with loss of oxygen and
glucose, however, has been proven unsuccessful [3].
Like other organs, the CNS has a remarkable ability to exert
endogenous protective pathways in the presence of non-toxic stress
and these defenses are capable of providing signiﬁcant protection
against otherwise lethal injuries. This phenomenon is referred to as
ischemic preconditioning or tolerance and was ﬁrst observed in the
brain over 40 years ago [4]. Ischemic tolerance can be achieved by a
host of stressful stimuli including low level exposure to oxidative
stress, mitochondrial toxins, CNS-speciﬁc antigens and hypoxia [5–9].
Modiﬁcations of ion channel activity, kinase activation and release of
adenosine and neurotransmitters may occur rapidly following the
preconditioning stimuli and result in a very brief window of
protection [10,11]. More sustained changes in gene activation and
protein synthesis which typically occur over the course of hours to
days are thought to lead to a longer window of cellular protection
[9,12,13]. Indeed, hallmark features of preconditioning include
dependence on new protein synthesis, activation of ATP dependent
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[14–16]. We have also shown that activation of traditional cytotoxic
agents such as reactive oxygen species (ROS) and caspases are also
essential to elicit the subsequent neuroprotection [9].
The suggested clinical correlate to preconditioning is transient
ischemic attacks (TIAs) prior to experiencing a stroke [17–19]. A TIA is
deﬁned as ‘a brief episode of neurologic dysfunction caused by focal
brain or retinal ischemia, with clinical symptoms typically lasting less
than 1 h, and without evidence of acute infarction’ [20]. Transient
ischemic attacks have increasingly been recognized as one of the
greatest immediate risk factors for ischemic stroke. Indeed, several
studies have cited that up to 18% of patients presenting with ischemic
stroke reported a history of TIA-like events [21–23]. Three major
studies have demonstrated that patients with a history of TIA exhibit a
better stroke outcome than those not experiencing a previous TIA
[24–26]. There is evidence that these patients have smaller initial
diffusion lesions along with less severe clinical deﬁcits following a
major stroke [25,27] although this remains controversial [28].
Based on multiple models of preconditioning protection, there is
clear linkage between the timing of the mild ischemic insults or other
stressors and the protective window afforded. Patients who experi-
ence TIAs fewer than 4 weeks prior to stroke onset experienced less
impairment one month following their stroke compared to those who
either had no history of TIA or TIAs beyond the 4 week window
[25,26]. To date, TIA studies have been limited due to small patient
sample size, variability between patient existing conditions, and the
lack of a diagnostic test for TIA.
The protective effects of a prior angina before myocardial ischemia
has, however, been more widely accepted and suggest that multiple
or protracted periods of angina are more protective than a single
episode alone (reviewed in [29]). Smaller studies in CNS have
suggested that patients with a history of multiple TIAs had a higher
proportion of favorable outcomes than patients with only one TIA
[26]. Basic science models of preconditioning, however, more
commonly rely on a single stressful insult to elicit protection
suggesting a need to develop a multiple exposure model of
preconditioning to capture the clinical realities of TIA and perhaps
afford greater protection than a single episode of preconditioning
stress.
In thiswork, we used a powerful newmicrophysiometry technique
tomeasure in real time neuronalmetabolic adaptations following brief
glucose deprivation in order to develop a newmodel of precondition-
ing thatmore closely resembles a history ofmultiple TIAs. Based on our
ﬁndings of favorable ATP production following a 5 minute oxygen
glucose deprivation (OGD), we exposed neurons to this mild stress
repeatedly over several days to determine if these cells expressed
hallmark features of preconditioning. These markers include tempo-
rally and spatially controlled caspase-3 activation, production of
reactive oxygen species and upregulation of the molecular chaperone
heat shock protein 70 (HSP70) [9,30–35].
2. Materials and methods
User-friendly versions of all of the protocols and procedures can be
found on our website at http://www.mc.vanderbilt.edu/root/vumc.
php?site=mclaughlinlab&doc=17838.
2.1. Materials and reagents
All media andmedia supplements were from Invitrogen (Carlsbad,
CA) except for themicrophysiometry experimentswhich used custom
RPMI (1 mM phosphate buffer, glucose and bicarbonate-free) from
Mediatech, Inc. (Manassas, VA). Antibodies for western blot analysis
and immunocytochemistry included rabbit cleaved caspase-3 poly-
clonal antibody (9661S) and anti-mouse IgG horseradish peroxidase
conjugated secondary antibody from Cell Signaling Technology(Danvers, MA), rabbit HSP70 polyclonal antibody (SPA-811) and
rabbit HSC70 polyclonal antibody (SPA-816) from Assay Designs (Ann
Arbor, MI), mouse microtubule associated protein 2 (MAP2) mono-
clonal antibody and Hoescht 33342 (DAPI) from Sigma (St. Louis,
MO), and anti-rabbit Cy-3 and anti-mouse Cy-2 from The Jackson
Immunoresearch Laboratory (Bar Harbor, ME). The modular hypoxic
chamber was purchased from Billups-Rothenberg Inc. (Del Mar, CA).
Western Lightning© chemiluminescence reagent plus enhanced
luminol reagents were from PerkinElmer Life Science (Waltham,
MA). Commercial kits utilized include DC Protein Assay Kit II from Bio-
Rad (Hercules, CA), OxyBlot™ Protein Oxidation Detection Kit from
Chemicon International (Billerica, MA), ViaLight® Plus Kit from
Cambrex Bioscience (East Rutherford, NJ) and LDH Toxicology Assay
Kit from Sigma.
Lyophilized alamethicin was obtained from A.G. Scientiﬁc, Inc.
(San Diego, CA) and reconstituted with 1 ml absolute ethanol.
Naﬁon® (perﬂuorosulfonic acid-PTFE copolymer, 5% w/w solution)
was from Alfa Aesar (Ward Hill, MA) while stabilized lactate oxidase
(LOx) was purchased from Applied Enzyme Technology (Pontypool,
UK). All Cytosensor® materials were purchased from Molecular
Devices Corporation (Sunnyvale, CA). Sterile 20% glucose solution
was purchased from Teknova (Hollister, CA). All other chemicals are
from Sigma.
2.2. Cell culture
Cortical cultures were prepared from embryonic day 16 Sprague–
Dawley rats as previously described with only minor modiﬁcations to
include new media supplements supporting neurite outgrowth [36].
Brieﬂy, cortices were dissociated and the resultant cell suspension
was adjusted to 770,000 cells/well (6-well tissue culture plates
containing poly-L-ornithine-treated coverslips) in growthmedia (80%
Dulbecco's Modiﬁed Eagle Medium (DMEM), 10% Ham's with F12-
nutrients, 10% bovine calf serum (heat-inactivated, iron-supplemen-
ted; Hyclone) with 24 U/ml penicillin, 24 μg/ml streptomycin, and
2 mM L-glutamine). Following the inhibition of glial cell proliferation
after two days in culture, neurons were maintained in Neurobasal
media (Invitrogen) containing B27 and NS21 supplements [37],
penicillin and streptomycin. All experiments were conducted three
weeks following dissection (21–25 days in vitro).
2.3. Neuronal oxygen glucose deprivation (OGD)
In vitro OGD experiments were performed as previously described
[38]. Mature neurons on glass coverslips were transferred to 35 mm
Petri dishes containing glucose-free balanced salt solution that had
been bubbled with an anaerobic mix (95% nitrogen and 5% CO2) for
5 min immediately prior to the addition of cells to remove dissolved
oxygen. Plates were then placed in a hypoxic chamber which was
ﬂushed with the anaerobic mix for 5 min, then sealed and placed at
37 °C for 10 or 85 min for a total exposure time of 15 and 90 min. OGD
treatment was terminated immediately following the 5 minute
exposure or after the longer exposure periods by placing the glass
coverslips into MEM media containing 10 mM Hepes, 0.01% bovine
serum albumin (BSA), and 2xN2 supplement (MEM/Hepes/BSA/
2xN2) under normoxic conditions.
2.4. Toxicity assays
Twenty four hours following each period of OGD insult, 40 μl of cell
media was removed and used to assess cell viability using a lactate
dehydrogenase (LDH)-based in vitro toxicity kit as previously
described [9,39]. In order to account for variation in total LDH
content, raw LDH values were normalized to the toxicity caused by a
24 hour exposure to 100 μMNMDA plus 10 μMglycine. This stress has
been shown to cause 100% cell death in this system [9,38]. All
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independent original dissections.
2.5. ATP assays
Measurements of ATP content were performed 24 h following 5,
15, or 90 min of OGD as described previously [38]. Brieﬂy, each
coverslip was removed from the toxicity plate and added to a new
plate containing 300 μl of Cell Lysis reagent from the ViaLight® Plus
Kit. Following a 10 minute incubation time, 80 μl of cell lysate and
100 μl of ATP monitoring reagent were added to each well of a 96 well
transparent plate. Bioluminescence due to the formation of light from
the interaction of the enzyme luciferase with cellular ATP was
measured on a Tecan Spectra Fluor Plus plate reader following a two-
minute incubation. Measurements were obtained in duplicate for
each sample with an integration time of 1000 ms and at a gain of 150
and normalized for protein levels. ATP levels are expressed as the
mean from at least three independent experiments±standard error
mean (S.E.M.). Statistical signiﬁcance was determined by two-tailed
paired t-test with pb0.05.
2.6. Microphysiometry analysis
Lactate-sensing electrode ﬁlms were prepared similarly to that
described previously [40,41]. Brieﬂy, 1.8 mg of LOx was dissolved in
100 μl of a BSA-buffer solution then quickly mixed with 0.8 μl of 25%
glutaraldehyde. Electrode ﬁlms were then prepared by allowing a
droplet of the enzyme solution to dry on the platinum electrode
surface of a modiﬁed Cytosensor® Microphysiometer plunger head
described previously [40–42]. A droplet of the 5% Naﬁon solution was
also applied to the oxygen electrode (127 μm bare platinum wire) to
reduce biofouling as shown in the literature [42,43]. The solutions
were prepared fresh for each experiment.
Lactate and oxygen measurements were performed with a multi-
chamber bipotentiostat enabling us to monitor multiple analytes in
four chambers simultaneously. The lactate-sensing electrodes were
held at a potential of +0.6 V to oxidize the H2O2 produced within the
enzyme ﬁlm while the oxygen electrode was set at−0.45 V to reduce
dissolved oxygen. All potentials were set versus the Cytosensor® Ag/
AgCl reference electrode in the efﬂuent stream.
Prepared cell inserts andmodiﬁed sensor heads were placed in the
four-channel microphysiometer as previously described [40]. Low-
buffered 5 mM glucose RPMI media was perfused through the
chamber at 100 μl per minute with the Cytosensor program main-
taining a pump-on/pump-off cycle (80 s pump-on and 40 s pump-
off). Lactate and oxygen signals were sampled by the potentiostat
once per second for the entirety of the experiment.
The neurons were perfused for 90 min, at which point the media
was replaced with an identical media containing no glucose and
perfused for either 5 or 90 min. Next, neurons were perfused with
5 mM glucose RPMI for an additional 120 min. Control experiments in
which no glucose deprivation occurred were performed simulta-
neously. The neurons were perfused with 15 μM alamethicin which
leads to formation of pores in the cellular membrane and cellular
death to allow for calibration of the lactate sensors.
Peak heights in nanoamps were calculated for each two-minute
pump-on/pump-off cycle. The average peak height measured after
neuron death was subtracted from each point. Molar lactate
production was calculated by comparing peak heights to the shifts in
baseline during the calibration steps. Molar oxygen was calculated by
assuming the oxygen baseline to be the concentration of dissolved
oxygen, ~0.24 mM, andwas calculated as described previously [44]. As
each chamber of cells differs slightly in neuron density and metabolic
activity, all signals were then normalized to 100% of the average signal
of 30 min before glucose deprivation. The data was boxcar smoothed
and replicate chambers were compared and grouped into four timepoints encompassing between 20 and 30 min for visualization and
include 0 min, 30 min, 1 h, and 2 h after glucose deprivation. The
average activity for lactate and oxygen at each pointwas normalized to
its control values and plotted as oxygen consumption or lactate
production vs. time. Each group was compared to the control and
statistical signiﬁcance was determined by a two-tailed paired t-test
with pb0.05.
2.7. Preconditioning paradigm
Mature neuronal cultures were exposed to 5 min of OGD and then
placed immediately into their original MEM/Hepes/0.01% BSA/2xN2
media. To determine if ROS were necessary for preconditioning,
neurons were treated with 500 μM N-tert-butyl-α-phenylnitrone
(PBN) during the daily OGD exposure period. Twenty four hours later,
neurons underwent an additional OGD exposure that was again
repeated the following day for a total of three OGD exposures over
three days. Every 24 h following the exposures, toxicity was
determined using LDH assays to evaluate cell death over time. Twenty
four hours following the last OGD period, control, preconditioned
only, or preconditioned with PBN neurons were exposed to 90 minute
OGD and toxicity was determined 24 h later using the LDH assay. For
longer survival studies, the 90 minute OGD period occurred 3 days
following the last 5 minute OGD exposure. Values were normalized to
100 μMNMDA toxicity. In order to assess if a multi-day treatment was
more effective than a single stress, experiments were performed in
which neurons were exposed to a single 5 minute OGD stress
followed by the 90 minute OGD 24 h later. Cellular death was then
determined the following day using the LDH toxicity assay.
2.8. Immunocytochemistry and quantiﬁcation
Neurons were ﬁxed with 4% paraformaldehyde and permeabilized
with 0.1% Triton X-100. The cells were then washed in phosphate
buffer solution (PBS) for a total of 15 min and blocked with 8% BSA in
PBS for 25 min. This was followed immediately by incubation in 1%
BSA in PBS solution containing cleaved caspase-3 primary antibody
(1:500) or MAP2 primary antibody (1:1000) at 4 °C overnight. Cells
were then washed in PBS for a total of 30 min followed by incubation
for 60 min in secondary antibodies diluted in 1% BSA. Cells were
washed again in PBS for a total of 25 min followed by a 10 minute
incubation in Hoescht 33342 (DAPI) to visualize nuclei [45]. Following
an additional 15 minute PBS wash, coverslips were mounted on slides
with Prolong Gold anti-fade reagent. Fluorescence was visualized
with a Zeiss Axioplan microscope equipped with an Apotome optical
sectioning ﬁlter as previously described [39]. The percentage of
cleaved caspase-3-positive cells was determined by counting the
number of cells that were positive for activated caspase and
normalizing to the total number of neurons as determined by DAPI
staining. Data represent the average±S.E.M. from at least three
independent experiments done in duplicate by two independent
blinded observers. Statistical signiﬁcance was determined by a two-
tailed paired t-test with pb0.05.
2.9. Oxyblot™ methodology
Twenty four hours following the third preconditioning OGD
exposure, neurons were harvested into 200 μl of TNEB (50 mM Tris,
2 mM EDTA 150 mM NaCl, 8 mM β-glycerophosphate, 100 μM ortho-
vanadate, 1% Triton X-100 (1%), 1:100 protease inhibitor) and total
oxidized proteins were determined using the OxyBlot™ Protein
Oxidation Detection Kit. Following the cell harvest, 100 μl of the lysate
was immediately treated with 50 mM DTT to prevent artiﬁcial protein
oxidation. The DTT treated lysate was split into two separate 50 μl
aliquots for the derivatization reaction containing 2,4-dinitrophenylhy-
drazine and the negative control containing derivatization control
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derivatization, equal protein concentrations were analyzed by western
blot using antibodies speciﬁc for the detection of oxidized proteins
provided by the manufacturer.
2.10. HSP70 analysis
Media was collected from control or preconditioned cultures
immediately prior to the 90 minute lethal injury. To concentrate the
extracellular media, 500 μl of sample for each condition underwent
centrifugal ﬁltration using microcon YM-30 centrifugal ﬁlter devices
from Millipore (Billerica, MA). The resulting concentrated media was
then used for western blot analysis to determine if HSP70 was present
extracellularly. The underlying neuronal cell bodies were washed
twice with ice cold PBS and harvested in 300 μl of TNEB lysate buffer
to evaluate intracellular HSP70 expression following preconditioning.
The constitutively expressed form of HSP70, HSC70, was used as a
loading control for intracellular HSP70. As a control, neurons were
exposed to 15 min of heat shock at 42 °C. The following day, media
was collected and neurons were harvested for western blot analysis of
HSP70 and HSC70.
Equal protein concentrations as determined by BCA protein assay
were separated using Criterion Tris–HCl gels (Bio-Rad), transferred to
polyvinylidene diﬂuoride membranes (Amersham Biosciences) and
incubated in the appropriate antibody (HSP70, 1:1000 or HSC70,
1:1000) as previously described [9]. Image J software (NIH) was used
to quantify the HSP70 western band intensity and data represents the
mean from three independent experiments±S.E.M. Statistical signif-
icance was determined by two-tailed paired t-test with pb0.05.
3. Results
3.1. Neuronal cells exhibit tolerance to brief OGD exposures
In order to establish a model of ischemic stress which more fully
captures the potentially repetitive nature of TIA stress and allows us to
assess neuronal speciﬁc adaptations necessary for preconditioning,
we ﬁrst exposed mature neuronal cultures to varying durations of
OGD. Twenty four hours later, neuronal death was assayed by
measuring the release of LDH into the culture media from dead and
dying cells. Neither 5 nor 15 min of OGD affected neuronal viability orFig. 1. Neurons can endure short periods of hypoxia. (A) Primary neuronal cultures were
measuring lactate dehydrogenase release. Data represent themean±SEM from 7 independen
post hoc analysis with pb0.05. (B) Representative photomicrographs taken 24 h after
architecture. Neurons from control conditions, following 5 or 15 min hypoxia have phase b
death with small debris evident and widespread neurite beading and retraction.disrupted cytoarchitecture whereas a 90 minute exposure resulted in
a signiﬁcant increase in LDH release compared to control cells
(Fig. 1A). Representative photomicrographs taken 24 h following
OGD demonstrate phase bright neurons with intact processes in
control, 5 or 15 minute exposed cultures (Fig. 1B, C, D). In contrast, a
90 minute exposure resulted in neuronal soma shrinkage, near
complete loss of phase bright cell bodies and evidence of neurite
beading and retraction (Fig. 1E).3.2. Neuronal energetic status is enhanced following mild stress
Given the immediate and profound metabolic consequences of a
loss of oxygen and glucose, we next evaluated the effects of mild,
moderate, and severe OGD on neuronal energetic status. Twenty four
hours following 5, 15, or 90 minute OGD, we measured total neuronal
ATP content and observed a signiﬁcant enhancement in ATP levels
following the non-toxic 5 minute exposure. Total ATP amounts were
not signiﬁcantly different from controls following at 15 minute OGD
which did not result in cellular death (Fig. 2A). Neurons exposed to
the 90 minute OGD experienced a profound loss of energetic reserves
as reﬂected by the 70% decrease in ATP which was statistically
indistinguishable from that elicited by a lethal exposure to 100 μM
NMDA (Fig. 2A).
Recent advances allow for the simultaneous detection of multiple
extracellular analytes to assess the relative contribution of aerobic
and anaerobic pathways in maintaining metabolic tone. Using
electrodes sensitive to lactate and oxygen, we performed real-time
measurements of neuronal oxygen consumption (aerobic) and
lactate production (anaerobic) immediately following 5 or 90 min-
ute glucose deprivation. Measurements of oxygen consumption
revealed a failure of cells which experience lethal glucose depriva-
tion to recover aerobic respiration. The non-toxic 5 minute expo-
sure, however, resulted in an enhancement of aerobic respiration
(Fig. 2B). Evaluation of anaerobic respiration by lactate generation
revealed that loss of glucose signiﬁcantly impaired anaerobic lactate
production following both the 5 and 90 minute exposure. Within
30 min following the initial 5 minute exposure, however, lactate
production was similar to that observed in control cells. In contrast,
the lethal 90 minute exposed neurons were unable to recover
anaerobic respiration and lactate production to control levels even
2 h following stress (Fig. 2C).exposed to 5, 15 or 90 minutes of hypoxia and cell death was assessed 24 h later by
t experiments. *denotes statistical signiﬁcance using a two-way ANOVAwith Dunnett’s
hypoxic exposure illustrate the effect of different exposure durations on neuronal
right somas with well deﬁned processes whereas the 90-min exposure results in cell
Fig. 2. Neuronal energetic status is preserved or enhanced with mild ischemia. (A)
Twenty four hours following 5, 15 or 90min of hypoxia, cellular ATP was assessed using
a bioluminescent reporter assay. ATP was increased following a 5-min hypoxic
exposure while 90-min hypoxia signiﬁcantly decreased total neuronal ATP. NMDA
treatment which is lethal to the neurons results in a dramatic collapse in ATP levels.
Data is normalized to control cellular ATP levels and represents themean±SEM from at
least 3 independent experiments. (B) Oxygen consumption and (C) lactate production
was measured at various time points following 5- or 90-min glucose deprivation using
microphysiometry. Neurons following the brief glucose deprivation recover both
oxygen consumption as well as lactate production within 30 min. Neither recover
following 90-min glucose deprivation. Data were normalized to control cell measure-
ments at the corresponding time point and represent the mean from at least 3
independent experiments. *denotes statistical signiﬁcance as compared to control cells
with pb0.05.
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Taken together, the toxicity and microphysiometry data suggest
that neurons are resistant to brief OGD episodes and that a single
episode places neurons in an aerobically poised state. To determine if
this state was neuroprotective, cultures were exposed to a single
5 minute OGD ormultiple 5 minute OGD periods on three consecutive
days. The day following the last exposure, control, single or multi-dayexposed neurons underwent 90 minute OGD (Fig. 3A). Representative
photomicrographs demonstrate that following three days of precon-
ditioning, neurons still exhibit healthy processes and phase bright
somas similar to control cultures (Fig. 3B, C, Supplementary Fig. 1).
Using LDH assays, we monitored cell death 24 h after each OGD
exposure and foundno difference between control, single ormulti-day
exposed cells reinforcing the visual inspection of the cells which
revealed no injury (Fig. 3D). Moreover, multiplemild stressors evoked
a preconditioning effect which did not occur following the single
stress. The effect of the normally lethal 90 minuteOGDwasdiminished
by 45% in cells experiencing the multiple preconditioning priming
(Fig. 3E, G). We also found a demonstrable increase in the protective
windowof thismulti-day preconditioning compared to our previous in
vitro single stress mixed culture model [46]. The preconditioning
protection was still evident three days following the last OGD
treatment (Fig. 3G).
3.4. Caspase-3 activation occurs following multi-day preconditioning
We have previously shown that spatially and temporally limited
activation of caspase-3 is essential for eliciting preconditioning
protection in our mixed neuronal/glia culture model of precondition-
ing protection [9]. In our model [47], limited caspase-3 proteolysis is
held in check by existing chaperones which are depleted in an effort to
target caspases for proteasomal degradation. This, in turn, leads to
upregulation of HSP70 and other neuroprotective proteins necessary
to survive a normally lethal stress.
As caspase activation occurs early in preconditioning following a
single stress [9], we evaluated cleaved caspase-3 expression 6 h
following each daily 5 minute OGD using immunoﬂuorescence. Quan-
tiﬁcation of caspase-3 positive cells as a percentage of total number of
cells revealed a signiﬁcant enhancement in caspase activation without
cell death following the repetitive 5 minute OGD periods in comparison
to either control or a single 5 minute treatment (Fig. 4A, B).
3.5. Neuronal preconditioning requires reactive oxygen species (ROS)
generation
In addition to caspase-3 activation being an essential mechanism to
deplete existing chaperones without production of ROS, both neuronal
as well as other types of cells do not evoke preconditioning defenses
[9,48]. In order to determine if ROS generation contributes to this new
repetitive stress enriched neuronal model, we ﬁrst determined the
amount of protein carbonyl formation using the OxyBlot™ methodol-
ogy. Following oxidative modiﬁcation of proteins by free radicals and
other reactive species, carbonyl groups are formed on protein side
chains which when incubated with dinitrophenylhydrazine are deriva-
tized into 2,4-dinitrophenylhydrazone which can be detected by
western blot analysis. In these experiments, we observed a substantial
increase in the amount of total oxidized proteins 24 h following the last
5 minute OGD treatment compared to control cells represented as a
greater intensity of staining in the preconditioned (Fig. 5A).
We used our previous strategy to determine if ROS productionwas
necessary for the neuroprotective potential of this preconditioning [9]
by blocking free radical interactions using the spin trap, PBN
(500 μm), during all three 5 minute OGD periods. Survival was
compared to preconditioned neurons in the absence of PBN following
90 minute OGD. PBN treatment signiﬁcantly decreased the neuropro-
tective effect of the multi-day preconditioning as exposure to 90 min
of OGD resulted in 90% cell death as determined by LDH (Fig. 5B).
3.6. HSP70 is upregulated and released by neurons following multi-day
preconditioning
New protein synthesis and upregulation of HSP70 are requisite
features of neuronal preconditioning [5,49] Using western blot
Fig. 3. In vitromodel of preconditioning using neuronal enriched cultures. (A) The experimental paradigm used to assess preconditioning protection. Neurons were exposed to 5 min
of hypoxia for 3 consecutive days. Twenty four hours following the last exposure, neurons were exposed to 90 min of hypoxia and cell survival was evaluated 24 h later.
Representative photomicrographs were taken 24 h after the last treatment to illustrate the extent of neuronal protection afforded by preconditioning. (B) Control cultures not
exposed to hypoxia showmany phase bright neurons and intact processes; (C) cultures exposed to 5 min oxygen glucose deprivation for 3 consecutive days also have well dispersed
processes and intact cell somas with no loss of viability. (D) Preconditioning itself is non toxic. Three consecutive days of non lethal preconditioning did not induce death as assessed
by LDH release measured 24 h following each 5-min exposure. (E) Cultures which were not preconditioned, but subsequently exposed to 90 min hypoxia underwent massive
neuronal cell death with no intact cell bodies whereas (F) preconditioned cultures hadmuch less cell death after a normally lethal hypoxic exposure. Many preconditioned cells were
phase bright as evident by the presence of manywell-deﬁned somas. (G) LDH release was assessed 24 h later showing preconditioned neurons exhibited 50% less death following 90
min hypoxia than naive neurons. Values were normalized to NMDA exposure which leads to 100% cell death (Ref). Data represent the mean from 6 independent experiments.
*denotes signiﬁcance as compared to control cells with pb0.05.
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expression 24 h following the last day of preconditioning (Fig. 6A). As
HSP70 has been shown by our group and others to alter cell fate when
applied extracellularly [9,50–53] andhas been shown to be released by
tumor cells [54–57], we next evaluated if neurons were releasing the
chaperone. We collected and concentrated the extracellular media
24 h following the last day of preconditioning and found a 3.3 fold
increase in HSP70 expression in preconditioned media compared to
control media (Fig. 6B). This data suggests that HSP70 was, indeed,
synthesized and released following preconditioning.4. Discussion
In this work, we developed a neuron-enriched culture system to
mimic multiple TIAs and observed that repeated exposure to brief
OGD provided robust neuroprotection against an otherwise lethal
stroke-like event. This model demonstrates many conserved features
of preconditioning including mild caspase activation, the necessity of
ROS generation for protection, and increased protein synthesis as
indicated by the upregulation of HSP70.The loss of aerobic metabolism and limitation of glucose following
ischemic occlusion has rapid and profound effects on CNS survival.
With limited capacity for anaerobic respiration, and few alternatives
to glucose as fuel, the loss of glucose rapidly impairs neuronal
function. Until recently, understanding the dynamic behaviors of
energetic pathways has been limited to static measures or indirect
assessment of metabolism. Using a novel microphysiometry system,
we were able to perform simultaneous measurements in real time of
neuronal metabolic recovery following glucose deprivation for the
ﬁrst time and observed that neurons quickly adapt to energetic
challenge. The brief loss of glucose is not only non-toxic as determined
by viability assays, but also allows for cells to rapidly recover as both
oxygen consumption and lactate production were similar to control
levels within 30 min. The fact that oxygen consumption was elevated
1–2 h following 5 minute glucose deprivation suggests that this stress
does not fatally impair or cause lasting dysfunction in either the
aerobic consumption of oxygen by the electron transport chain nor
does it cause irreversible reliance on anaerobic respiration as would
be reﬂected in a larger increase in lactate.
In contrast, neurons exposed to the lethal 90 minute glucose
deprivation did not recover aerobic respiratory capacity. Given that
Fig. 4. Mild activation of caspase 3 is maximal after the second round of preconditioning. (A) Six hours after each round of ﬁve minutes of hypoxia, cells were stained with an
antibody recognizing cleaved caspase 3 (red), MAP2 (green) and DAPI (blue). (B) Quantiﬁcation of cleaved caspase 3 positive neurons indicates an increased protease cleavage in PC
neurons compared to control. Data represent the mean from 3 independent experiments ±SEM. *denotes statistical signiﬁcance compared to control cells.
Fig. 5. Preconditioned cells undergo signiﬁcant oxidative stress which is required for neuroprotection. (A) Protein oxidation was assessed in culture extracts using Oxyblot
visualization of proteins with carbonyl groups formed by oxidative and nitrosylative stress. Proteins were harvested 72-h following initiation of preconditioning (PC) or control
conditions and were treated with 2,4-dinitro phenyl hydrazine derivatization (Deriv) or Negative control (Neg.) reactions. An increase in oxidized proteins was evident following
preconditioning. (B) Addition of the free radical spin trap PBN (500 μM) during the 5 min hypoxic preconditioning periods increased neuronal death assessed by LDH assay in the
preconditioned cultures following a 90-min hypoxic exposure. Data represent the mean±SEM for 3 independent experiments. *denotes statistical signiﬁcance compared to control.
Δ denotes statistical signiﬁcance compared to preconditioned neurons.
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Fig. 6. HSP70 is upregulated and released into the extracellular media following preconditioning. Twenty four hours following the last 5-min hypoxic exposure, intracellular and
extracellular HSP70 was assessed using western blot analysis. (A) Intracellular HSP70 levels were not altered following PC whereas a signiﬁcant release of HSP70 was evident
following PC compared to control cells. Heat shocked cells (HS) exhibited much higher intracellular and extracellular HSP70 expression. HSC70 expression was used as a protein
loading control. (B) NIH image J analysis was used to quantify the intensity of each band. Data represent the mean±SEM for 4 independent experiments. *denotes statistical
signiﬁcance compared to control neurons with pb0.05.
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efﬁciently adapt to non-lethal metabolic stress. Taken in conjunction
with our ATP studies demonstrating higher ATP levels 24 h following
a 5 minute OGD, this data suggests that neurons have adapted their
metabolic pathways to build an ATP surplus necessary for surviving an
otherwise lethal stress. These data are in contrast to our recently
published report in mixed cultures comprised of 80% glia and 20%
neurons where total ATP levels were simply comparable to control
levels 24 h after a single preconditioning event. Taken together, this
work suggests that the neuronal enriched cultures exposed to multi-
day stressors evoke unique adaptive metabolic features which are not
observed following a single stress in a mixed culture enriched for glia.
In addition to online assessment of lactate production and oxygen
consumption, our microphysiometry system can be equipped with
electrochemical detectors to measure extracellular glucose and pH
[40,42,43].While alterations in theacidiﬁcation ratemaynot necessarily
represent changes in anaerobic metabolism, as pH can be modiﬁed by
CO2 production, the combination of lactate and acidiﬁcation sensors
allows a more comprehensive view of neuronal metabolism [58]. We
believe that this powerful four-analyte system will ultimately allow us
todevelop aneuronalmetabolic biosignature to determine the temporal
windowsof relianceupon aerobic and anaerobicmetabolism in stressed
cells and determine the best substrates to increase neural survivalwhen
oxygen or glucose is limiting.
As for the later signaling systems which are employed by neurons
to evoke neuroprotection, we had already come to appreciate that
preconditioning protection is strictly temporally limited. Using a single
sublethal stress, this window of protection lasts between 24 and 48 h
in our mixed neuron/glia preconditioning model [9]. Using this new
neuron-enriched multi-day preconditioning paradigm, we observed
an enhanced window of protection lasting a minimum of three days.
While not previously done in cortical or hippocampal systems, Gidday
and colleagues have shown that repetitive mild OGD stress over
12 days resulted in increased retinal ischemic tolerance from 1–3 days
to weeks [59]. The current working model is that multiple episodes of
sublethal stress likely evoke long term genomic reprogramming
similar to that which occurs in hibernation or following exposure to
high altitude and/or low oxygen conditions [12].
From a clinical standpoint, we recognize that the incidence of both
TIA and stroke increases with age and risk factors such as diabetes,obesity and abnormal lipid proﬁles are strong risk factors for both
forms of ischemia. The ability of neurons to induce many of the
protective pathways outlined in this work and in other models of
preconditioning, may reasonably be expected to be less vigorous or
even already in place in the aged, patients experiencing chronic
hypertension or hyperglycemia [60], so we look with great interest to
developing clinical measures which account for cumulative oxidative
stress provided by increased lipid peroxidation or protein dysfunction
in those at high risk of TIA or stroke as possible predictors of the ability
to mount rigorous defenses against sublethal stress.
It is worth noting that while our neuronal preconditioning model
shares a reliance on new protein synthesis, caspase activation and ROS
production to elicit protection, the mechanism by which HSP70
evokes protection is more complicated than we originally anticipated.
Most of the work on the neuroprotective action of chaperones has
focused on HSP70 as an intracellular regulator of protection by
limiting caspase activation, aiding in protein refolding or targeting
proteins for proteasomal degradation [9,61]. In this new multi-day
stress model of preconditioning, HSP70 was found to be released into
the extracellular media.
HSP70 release has been demonstrated following stress in glial
tumors, neuroblastomas and following systemic or immune stress
[62–68]. The release of HSP70 is thought to occur via exosomes and
lipid rafts along with the activation of extracellular-signal-regulated
kinase and phosphatidylinositol-3-kinase pathways and many of
these signaling molecules and pathways have been linked to
preconditioning as well [64,66,69–73]. This is the ﬁrst work, however,
demonstrating the release of HSP70 following preconditioning. As
cellular death was similar between control and preconditioned
neurons, this extracellular pool of HSP70 is not due to a release
from dead and dying cells. While heat shocked neurons exhibited a
high level of intracellular HSP70, extracellular HSP70 was only
modestly impacted suggesting that following extreme stress HSP70
may be sequestered and recruited to sites of intracellular injury as its
chaperone function is maximally required. In contrast, we hypothe-
size that amild stress requires less of a role for intracellular HSP70 and
allows for release into the extracellular space. Taken in conjunction
with the neuroprotective effect of puriﬁed HSP70 application to cells
[9,50,74,75], we believe this release may be important for precondi-
tioning neuroprotection.
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we seek to develop a fuller understanding of the implications of the
elevations in plasma and CSF levels of HSP70 and other chaperones
that have been observed clinically [76–79]. As HSP70 is necessary for
preconditioning cytoprotection, analyzing its release into the cerebral
spinal ﬂuid and other peripheral specimens may serve as a useful
biomarker for CNS ischemia. Indeed, gene expression in peripheral
blood varies between rats treated with brief focal ischemia or stroke
[80]. Currently, TIAs are diagnosed primarily by patient history as
there are no diagnostic markers of TIA if symptoms have resolved
upon emergency room admittance [81,82]. Given that 10% of
emergency room TIA patients return within 48 h with a stroke [83],
a TIA biomarkermay be beneﬁcial in deﬁning ischemic events andwill
allow us to determine if HSP70 release, markers of chronic stress or
altered metabolic proﬁle correlates with a better outcome upon
secondary injury. We believe that comprehensive metabolic proﬁling
in conjunction with traditional biochemical and high throughput
screening will allow us to identify essential proteins for energetic
compensation as well as novel targets for stroke therapy as well as to
deﬁning best practices for glucose, oxygen, and lactate management
in stoke patients.
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